Beruflich Dokumente
Kultur Dokumente
more than 50% of the therapeutic encounters. As observed in this study, 97% of cases were treated empirically without culture and sensitivity report. Ciprofloxacin is cheap, safe and effective against most of the organisms invading eye3. In the treatment of conjunctivitis and blepharitis, it has been reported that chloramphenicol and ciprofloxacin showed no significant difference in efficacy and safety 4. In case of bacterial keratitis, the success rate was 92% with ciprofloxacin while that was 88% with combination therapy of cefazolin and gentamicin5. In case of corneal ulcer, 97-98% success rate was observed when ciprofloxacin was combined with cephazolin or gentamicin 6. The treatment pattern observed in the OPD of SCB. Medical College,Cuttack, corroborates with the accepted pattern of treatment of ocular diseases. Fluroquinolones such as enoxacin, fleroxacin, levofloxacin, pefloxacin and sparfloxacin are currently being developed as ocular agents. Whether their use as a topical agent will lead to development of drug resistance has to be monitored. M. MOHANTY*, S. MOHAPATRA Department of Pharmacology, SCB Medical College, Cuttack-753 007. *M A - 31, BRIT Colony, Nayapalli, Bhubaneswar-751 012. E-mail: drmmohanty@hotmail.com REFERENCES
1. W H O. DAP 93.1: How to investigate drug use in health facilities. Selected drug use indicators. Action programme on essential drugs. 1995. Biswas NR. Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi. Br J Clin Pharmacol 2001;51:267- 9. Lucy C. Continuing education. J Pharm 2000;264:441 -5. Power WJ, Collum LM, Easty DL, Bloom PA, Laidlaw DA, Libert J, et al . Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol. Eur J Ophthalmol 1993;3:77-82. Liebowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:34-47. Bower. Fluoroquinolones in the treatment of bacterial keratitis. Am J Ophthalmol 1996;121:712-5.
2.
3. 4.
5.
6.